Ruby Anto | Drug Discovery and Development | Best Researcher Award

Dr. Ruby Anto | Drug Discovery and Development | Best Researcher Award

Centre of Excellence in Nutraceuticals | India

Dr. Ruby Anto is a distinguished biochemist and cancer researcher with an extensive career dedicated to advancing the fields of molecular oncology, bioimmunotherapy, and nutraceutical science. She currently serves as Chief Scientist at the Centre of Excellence in Nutraceuticals, KSCSTE, Government of Kerala, Thiruvananthapuram, and Honorary Scientist at the Institute of Advanced Virology, Thiruvananthapuram. Over her accomplished career, she has held numerous scientific positions at the Rajiv Gandhi Centre for Biotechnology, progressing from Research Associate to Scientist G, reflecting her consistent contributions and leadership in biomedical research.Dr. Anto earned her PhD in Biochemistry from Amala Cancer Research Centre, Thrissur, following her postgraduate studies in Chemistry and Education. Her multidisciplinary academic background—combining chemistry, biochemistry, and pedagogy—has been central to her innovative approach to cancer biology and molecular medicine. Her early academic achievements and later professional experiences at prestigious institutions such as the M.D. Anderson Cancer Center, Houston, provided a strong foundation for her research on targeted cancer therapies, chemopreventive agents, and the role of natural products in disease modulation.Recognized nationally and internationally for her scientific excellence, Dr. Anto has received several prestigious honors, including the Young National Women Bio-Scientist Award from the Department of Biotechnology, Government of India, and fellowships from the National Academy of Sciences, India, and the Academy of Sciences, Thiruvananthapuram. Her professional journey also includes global training experiences, such as her participation in the Clinical Trials Traineeship Program at INSERM, Paris, which broadened her expertise in translational research and clinical validation of nutraceutical interventions.As a mentor, Dr. Anto has nurtured a generation of young scientists, with her students and postdoctoral fellows earning numerous national and international awards for their work in cancer biology and nutraceutical research. Her leadership has fostered a thriving academic environment focused on the discovery and characterization of bioactive compounds from natural sources with therapeutic potential.Dr. Anto’s scientific publications have advanced understanding in areas such as natural compound-mediated cancer prevention, signaling pathway modulation, and anti-inflammatory mechanisms of nutraceuticals. Through her research, she continues to bridge the gap between basic biochemistry and applied health sciences, promoting nutraceutical innovation as a cornerstone of preventive and personalized medicine. Her lifelong dedication to scientific inquiry and mentorship underscores her status as one of India’s leading voices in biochemistry and nutraceutical research.

Profile: Google Scholar

Featured Publications

Ruby, A. J., Kuttan, G., Babu, K. D., Rajasekharan, K. N., & Kuttan, R. (1995). Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Letters, 94(1), 79–83.

Anto, R. J., Mukhopadhyay, A., Denning, K., & Aggarwal, B. B. (2002). Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: Its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis, 23(1), 143–150.

Anto, R. J., Sukumaran, K., Kuttan, G., Rao, M. N. A., Subbaraju, V., & Kuttan, R. (1995). Anticancer and antioxidant activity of synthetic chalcones and related compounds. Cancer Letters, 97(1), 33–37.

Oommen, S., Anto, R. J., Srinivas, G., & Karunagaran, D. (2004). Allicin (from garlic) induces caspase-mediated apoptosis in cancer cells. European Journal of Pharmacology, 485(1–3), 97–103.*

Anto, R. J., Mukhopadhyay, A., Shishodia, S., Gairola, C. G., & Aggarwal, B. B. (2002). Cigarette smoke condensate activates nuclear transcription factor-κB through phosphorylation and degradation of IκBα: Correlation with induction of cyclooxygenase-2. Carcinogenesis, 23(9), 1511–1518.*

Bava, S. V., Puliappadamba, V. T., Deepti, A., Nair, A., Karunagaran, D., & Anto, R. J. (2005). Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-κB and the serine/threonine kinase Akt and is independent of tubulin polymerization. Journal of Biological Chemistry, 280(8), 6301–6308.*

Srinivas, G., Anto, R. J., Srinivas, P., Vidhyalakshmi, S., Senan, V. P., & Karunagaran, D. (2003). Emodin induces apoptosis of human cervical cancer cells through poly (ADP-ribose) polymerase cleavage and activation of caspase-9. European Journal of Pharmacology, 473(2–3), 117–125.*

Zuzana Sekeyová | Formulation Science | Best Researcher Award

Mrs. Zuzana Sekeyová | Formulation Science | Best Researcher Award

Slovak Academy of Sciences | Slovakia

Mrs. Zuzana Sekeyová is a highly accomplished virologist and microbiologist with extensive expertise in the study, diagnosis, and prevention of rickettsial and intracellular pathogens. She obtained her Bachelor’s and Master’s degrees in Virology from Comenius University, Bratislava, and completed her Ph.D. at the Faculty of Natural Sciences, Comenius University, focusing on the biology of Rickettsiae and related organisms at the Institute of Virology, Slovak Academy of Sciences. She advanced her knowledge through postdoctoral training at the University of Maryland, Department of Microbiology and Immunology, Baltimore, USA, and through multiple visiting research fellowships supported by the Deutsche Akademische Austauschdienst (DAAD) at Justus Liebig Universität, Giessen, Germany, and the WHO Collaborative Center for Rickettsial Reference and Research, CNRS UPRESA 6020, Marseille, France. She further enhanced her global expertise as a visiting research fellow with the Japan Society for the Promotion of Science at Obihiro University of Agriculture & Veterinary Medicine and the National Institute of Infectious Diseases in Tokyo, Japan.Mrs. Sekeyová began her career as a scientific assistant and young scientist at the Institute of Virology, Slovak Academy of Sciences, progressing to senior research scientist and deputy head of the Department of Rickettsiology, where she currently oversees the Laboratory for Diagnosis and Prevention of Rickettsial and Chlamydial Infections. She serves as an expert verifier for the Slovak National Accreditation Service under the Good Laboratory Practice Compliance Program and is a key member of the National Reference Center for Surveillance and Laboratory Diagnostics of Rickettsiae. She is also an internationally recognized expert in synthetic biology, participating in the Open Ended Online Forum and the Ad Hoc Technical Expert Group under the United Nations Convention on Biological Diversity.Her research emphasizes the molecular biology, epidemiology, and diagnostics of rickettsial and related intracellular microorganisms, contributing to innovative detection methods and preventive strategies. Notable publications include Evaluation of cytotoxic activity against A549 human lung cancer cells using green synthesized N-Cholyl D-Penicillamine encapsulated silver and gold nanoparticles, Mucoadhesive and drug release of cholic acid based thiomeric micelles and encapsulated silver and gold nanoparticles for anticancer studies, and C-type natriuretic peptide induces cell death and sensitizes the effect of cisplatin in human non-small cell lung cancer cells. Through decades of research, Mrs. Sekeyová has combined rigorous laboratory investigations with translational and global health applications, establishing herself as a leading authority in virology, rickettsial diseases, and synthetic biology, with a strong commitment to advancing international scientific collaboration and public health initiatives.

Profile: Orcid

Featured Publications

Špitalská, E., Sabaka, P., Komorníková, A., Minichová, L., Palkovičová, K., Fenollar, F., Škultéty, Ľ., Miková, E., Sekeyová, Z., & Fournier, P.-E. Abdominal manifestations of Q fever. International Journal of Infectious Diseases.

Danchenko, M., Benada, O., Škultéty, Ľ., & Sekeyová, Z. Culture Isolate of Rickettsia felis from a Tick. International Journal of Environmental Research and Public Health.

Sekeyová, Z. Case studies of rickettsiosis, anaplasmosis and Q fever in Slovak population from 2011 to 2020. Biologia.

Sekeyová, Z. Detection of Rickettsia raoultii in Dermacentor reticulatus and Haemaphysalis inermis ticks in Slovakia. Biologia.

Sekeyová, Z. Hymenopteran Parasitoids of Hard Ticks in Western Africa and the Russian Far East. Microorganisms.

Giorgio Gargari | Personalized Medicine | Best Paper Award

Assist. Prof. Dr. Giorgio Gargari | Personalized Medicine | Best Paper Award

University of Milan | Italy

Assist. Prof. Dr. Giorgio Gargari is an accomplished researcher and academic in the Department of Food, Environmental and Nutritional Sciences at the University of Milan. His academic and research journey reflects a deep commitment to advancing the understanding of the intricate relationships between diet, the gut microbiome, and host physiology. With a strong foundation in biological sciences and food sciences, Dr. Gargari has developed expertise that bridges molecular biology, bioinformatics, and nutritional science, focusing on how dietary interventions influence microbiome composition and functionality. He is a highly skilled bioinformatician and biostatistician, proficient in computational biology, data analysis, and multi-omics integration. His work explores the triangular interaction between diet, microbiome, and host systems, aiming to elucidate how microbial ecosystems mediate the effects of food on health. His scientific approach integrates both experimental and computational methods to identify microbial pathways that contribute to human health and disease prevention. Dr. Gargari’s research has provided valuable insights into gut microbiome modulation through probiotics, polyphenol-rich diets, and microbial metabolites such as short-chain fatty acids. His publications demonstrate his capacity to translate complex biological data into clinically meaningful applications, particularly in the context of inflammatory regulation, gastrointestinal health, and precision nutrition.Dr. Gargari has published extensively in high-impact, peer-reviewed journals, contributing to a body of literature that continues to shape modern nutritional and microbiome research. His work has gained recognition in international conferences and scientific meetings, where he has been an invited speaker on topics such as microbial ecology in winemaking, gut microbiota modulation, and the metabolic effects of dietary components. He has also contributed to projects funded by major research institutions, coordinating studies on the transformation of agro-food waste into valuable biostimulants and microbial ecosystems for sustainable production.As an educator and academic leader, Dr. Gargari plays an active role in multiple degree programs, including Human Nutrition and Dietetics, Food Technology, and Bioinformatics for Comparative Genomics. He has supervised and mentored numerous students and has served on several thesis committees. His contributions to the scientific community have been recognized through various awards and international honors, reflecting his excellence in research, teaching, and innovation.

Profile: Orcid

Featured Publications

Gargari, G., Meroño, T., Peron, G., Del Bo’, C., Marino, M., Cherubini, A., Andres-Lacueva, C., Kroon, P. A., Riso, P., & Guglielmetti, S. (n.d.). Effect of a polyphenol-rich dietary pattern on subjects aged ≥ 60 years with higher levels of inflammatory markers: Insights into microbiome and metabolome. Microbiome Research Reports.

Marzano, M., Thakur, R. S., Bicciato, S., Raneri, M., Guglielmetti, S., Grassi, F., Mangani, D., De Ponte Conti, B., Pesole, G., Gargari, G., et al. (n.d.). Secretory IgA amplification during immune checkpoint blockade enhances the control of tumor growth by enterotropic T cells. Science Advances.

Laterza, L., Cremon, C., Coppola, G., Settanni, C. R., Maresca, R., Strazzeri, M., Durini, E., Petito, V., Scaldaferri, F., Gargari, G., et al. (n.d.). Multistrain probiotics plus vitamin D improve gut barrier function and gut microbiota composition in irritable bowel syndrome without constipation: Results from a double-blind, randomized, placebo-controlled trial. Nutrients.

Duncan, R., Mantegazza, G., Gargari, G., Pierallini, E., Russo, R., & Guglielmetti, S. (n.d.). Heyndrickxia coagulans LMG S-24828 is a safe probiotic strain capable of germinating in the human gut. Probiotics and Antimicrobial Proteins.

Gargari, G., Mantegazza, G., Taverniti, V., Gardana, C., Valenza, A., Rossignoli, F., Barbaro, M. R., Marasco, G., Cremon, C., Barbara, G., et al. (n.d.). Fecal short-chain fatty acids in non-constipated irritable bowel syndrome: A potential clinically relevant stratification factor based on catabotyping analysis. Gut Microbes.

Speciani, M. C., Gargari, G., Penagini, R., Mutignani, M., Ferraroni, M., Natale, A., Katsoulis, M., Cintolo, M., Leone, P., Airoldi, A., et al. (n.d.). Garlic consumption in relation to colorectal cancer risk and to alterations of blood bacterial DNA. European Journal of Nutrition.

Mutignani, M., Penagini, R., Gargari, G., Guglielmetti, S., Cintolo, M., Airoldi, A., Leone, P., Carnevali, P., Ciafardini, C., Petrocelli, G., et al. (n.d.). Blood bacterial DNA load and profiling differ in colorectal cancer patients compared to tumor-free controls. Cancers.

Amanda Gollo Bertollo | Neuropharmacology | Best Researcher Award

Mrs. Amanda Gollo Bertollo | Neuropharmacology | Best Researcher Award

Federal University of Santa Catarina | Brazil

Mrs. Amanda Gollo Bertollo is an accomplished biomedical and neuroscience researcher with extensive experience across molecular biology, genetics, and biomedicine. Currently, she serves as a Biology Expert at Turing, providing expert review and guidance on molecular biology and genetics tasks to ensure scientific accuracy in AI-driven projects. She is pursuing her Ph.D. in Neurosciences at the Federal University of Santa Catarina, focusing on the hypothalamus-pituitary-adrenal and gut-brain axes in the biological interaction pathways of depression. Her research portfolio spans neuroscience, psychiatric disorders, and molecular mechanisms underlying mental health conditions.Previously, Mrs. Bertollo completed her Master’s in Biomedical Sciences at the Federal University of Fronteira Sul, where she conducted advanced research, authored, and critically reviewed scientific publications. She has also gained hands-on clinical and teaching experience as a Portuguese Writing Specialist at Outlier, a Personal English Teacher, and an English Instructor at Wizard Idiomas, developing personalized curricula and evaluating the accuracy of academic and creative content. Her practical biomedical training includes supervised internships in neurology at Western Regional Hospital and at the Family Health Center, where she contributed to patient care and clinical research activities. She earned her Bachelor of Science in Nursing from the Federal University of Fronteira Sul, providing a strong foundation in patient care, biomedical research, and clinical practice. Additionally, she is pursuing undergraduate studies in Computer Science, reflecting her interdisciplinary approach bridging computational methods with biological and clinical research.Mrs. Bertollo has authored and contributed to numerous influential publications, including “Hypothalamus-pituitary-adrenal and gut-brain axes in biological interaction pathway of the depression,” “Neurobiological Relationships Between Neurodevelopmental Disorders and Mood Disorders,” and “Biological rhythms and psychiatric symptoms in COVID-19 individuals: a cross-sectional multicentric study.” Her work further explores topics such as the impact of melatonin on cytokine storms and purinergic receptor modulation for COVID-19 prognosis, dementia and depression connections with amyloid β protein, early life stress and major depressive disorder, depressive-like behaviors influenced by Centella asiatica extracts, neurobiological mechanisms in the kynurenine pathway, peripheral biomarkers predicting COVID-19 prognosis, and the role of ABO blood type and metabolic markers in COVID-19 susceptibility and severity. Through her multidisciplinary research, Mrs. Bertollo has made substantial contributions to the understanding of neurobiological pathways, psychiatric disorders, and the clinical implications of metabolic and immunological biomarkers, establishing herself as a rising expert in neurosciences and biomedical sciences.

Profile: Orcid

Featured Publications

Bertollo, A. G., Santos, C. F., Bagatini, M. D., & Ignácio, Z. M. Hypothalamus-pituitary-adrenal and gut-brain axes in biological interaction pathway of the depression. Frontiers in Neuroscience.

Bertollo, A. G., Mocelin, R., & Ignácio, Z. M. Pharmacogenetics and the response to antidepressants in major depressive disorder. Pharmaceuticals.

Mattia-Maximiano, B. C., Mioranza-Koppe, M., Silva, R. H., Arent, C. O., Amboni, G., Pedro, L. C., Bertollo, A. G., Dellazeri Cortez, A., de Medeiros, J., Pedrotti Moreira, F., et al. Biological rhythms and psychiatric symptoms in COVID-19 individuals: a cross-sectional multicentric study. Biological Rhythm Research.

Bertollo, A. G., Puntel, C. F., da Silva, B. V., Martins, M., Bagatini, M. D., & Ignácio, Z. M. Neurobiological relationships between neurodevelopmental disorders and mood disorders. Brain Sciences.

Bertollo, A. G., Mingoti, M. E. D., & Ignácio, Z. M. Neurobiological mechanisms in the kynurenine pathway and major depressive disorder. Reviews in the Neurosciences.

Bertollo, A. G., da Silva, B. V., Martins, M., Bagatini, M. D., & Ignácio, Z. M. Neurobiological relationships between neurodevelopmental disorders and mood disorders.

Liangxing Tu | Drug Delivery Systems | Best Researcher Award

Prof. Liangxing Tu | Drug Delivery Systems | Best Researcher Award

Jiangxi University of Chinese Medicine | China

Prof. Dr. Liangxing Tu is a distinguished pharmaceutical scientist recognized for his extensive contributions to drug delivery systems and biopharmaceutics. He earned his Ph.D. in Pharmaceutics from the Shanghai University of Traditional Chinese Medicine, where he developed a strong foundation in advanced pharmaceutical formulations and nanotechnology-based therapeutics. After completing his doctoral studies, he began his professional journey at FosunPharma in Shanghai, where he contributed to pharmaceutical innovation and product development. He later joined the Jiangxi University of Traditional Chinese Medicine, where he currently serves as the Director of the Division of Innovative Pharmaceutical Sciences, leading cutting-edge research in formulation science and nanomedicine.Dr. Tu’s research focuses on developing advanced drug delivery systems, including nanocrystals, polymeric micelles, and vesicular systems, to enhance the oral bioavailability and therapeutic efficacy of poorly soluble drugs. His work also extends to exploring biopharmaceutics mechanisms to improve the in vivo performance of active pharmaceutical ingredients. His innovative approaches have positioned him at the forefront of translational pharmaceutics, bridging the gap between laboratory research and clinical applications.He is an active member of the Chinese Pharmaceutical Association and contributes his expertise as a member of the Elsevier Advisory Panel. Additionally, he serves on the Editorial Board of Chinese Chemical Letters (ISSN: 1001-8417), reflecting his strong academic presence and influence in the pharmaceutical sciences community. Dr. Tu has been awarded multiple research grants, including projects funded by the National Natural Science Foundation of China and other governmental bodies, underscoring the national and international recognition of his research excellence.Dr. Tu has published around 30 peer-reviewed papers in top-tier journals such as Chinese Chemical Letters, Drug Delivery, and the International Journal of Pharmaceutics. His representative publications include “Vesicular Drug Delivery Systems for Oral Absorption Enhancement,” “Multi-functional Chitosan Copolymer Modified Nanocrystals as Oral Andrographolide Delivery Systems for Enhanced Bioavailability and Anti-inflammatory Efficacy,” “Fabrication of Ultra-Small Nanocrystals by Formation of Hydrogen Bonds: In Vitro and In Vivo Evaluation,” “Multi-functional Chitosan Polymeric Micelles as Oral Paclitaxel Delivery Systems for Enhanced Bioavailability and Anti-Tumor Efficacy,” and “Study on the Preparation of Stabilizer-Free Silymarin Nanocrystals and Its Oral Absorption Mechanisms.”

Profile: Orcid

Featured Publications

Wang, J., Sun, Y., Meng, L., Feng, J., Cheng, M., & Tu, L. Intestinal transporters and oral absorption enhancing strategies based on these transporters. Chinese Chemical Letters.

Li, Z., Yao, L., Liu, Z., Wang, L., Ruan, H., Shen, Y., Zhang, P., Li, K., Wang, H., Fan, L., et al. Andrographolide Sulfonates and Xiyanping: A Review of Chemical Composition, Pharmacological Activities, Clinical Applications, and Adverse Reactions. Pharmaceuticals.

Tu, L., Wang, J., Sun, Y., & Wan, Y. Fabrication of Luteolin Nanoemulsion by Box-Behnken Design to Enhance its Oral Absorption Via Lymphatic Transport. AAPS PharmSciTech.

Zou, L., Cheng, M., Hu, K., Feng, J., & Tu, L. Vesicular drug delivery systems for oral absorption enhancement. Chinese Chemical Letters.

He, Y., Cheng, M., Yang, R., Li, H., Lu, Z., Jin, Y., Feng, J., & Tu, L. Research Progress on the Mechanism of Nanoparticles Crossing the Intestinal Epithelial Cell Membrane. Pharmaceutics.

Liu, W., Cheng, M., Yuan, F., He, J., Feng, Y., Jin, Y., Yang, S., Feng, J., & Tu, L. Enhancing oral bioavailability of andrographolide via sodium dodecyl sulfate and D-α-Tocopherol polyethylene glycol 1000 succinate copolymer modified nanocrystals. Journal of Drug Delivery Science and Technology.

Liu, W., Cheng, M., Lu, Z., Li, H., Feng, Y., Jin, Y., Yang, S., Feng, J., & Tu, L. Multi-functional chitosan copolymer modified nanocrystals as oral andrographolide delivery systems for enhanced bioavailability and anti-inflammatory efficacy. Drug Delivery.

Basant Farag | Drug Discovery and Development | Best Researcher Award

Dr. Basant Farag | Drug Discovery and Development | Best Researcher Award

Zagazig University Faculty of Science | Egypt

Dr. Basant Farag is a distinguished organic chemist and assistant lecturer at the Department of Chemistry, Faculty of Science, Zagazig University, Egypt, with extensive expertise in the synthesis, biological evaluation, and computational studies of heterocyclic compounds. She completed her Ph.D. in Organic Chemistry at Zagazig University, building on her M.Sc. and B.Sc. degrees in the same field, demonstrating a consistent commitment to advancing chemical sciences. Her academic career encompasses teaching, mentoring students, and conducting cutting-edge research while serving as a teaching assistant and assistant lecturer, preparing lectures, evaluating students, and engaging in independent research projects. Dr. Farag is also an accomplished international reviewer for numerous journals including Chemistry Select, Eurasian Journal of Chemistry, Journal of Molecular Structure, Bioorganic Chemistry, and International Journal of Biological Macromolecules, highlighting her broad expertise and recognition in the global scientific community.Her research portfolio includes pioneering studies in the design and synthesis of biologically active heterocyclic compounds, focusing on pharmacologically relevant molecules with anticancer, antimicrobial, and antitubercular properties. Her notable publications include Synthesis and Molecular Docking of Some Novel 3-Thiazolyl-Coumarins as Inhibitors of VEGFR-2 Kinase, Mechanochemical Synthesis and Molecular Docking Studies of New Azines Bearing Indole as Anticancer Agents, Green Synthesis and Molecular Docking Study of Some New Thiazoles Using Terephthalohydrazide Chitosan Hydrogel as Ecofriendly Biopolymeric Catalyst, Green Route Synthesis and Molecular Docking of Azines Using Cellulose Sulfuric Acid under Microwave Irradiation, Synthesis, Molecular Docking and Anticancer Activity of Some 5-Aryl-5,10-Dihydropyrido[2,3-d:6,5-d′]Dipyrimidine-2,4,6,8-Tetraone Derivatives and Pyrido[2,3-d], Synthesis, Molecular Docking Study, and Biological Evaluation of New Thiadiazole and Thiazole Derivatives Incorporating Isoindoline-1,3-Dione Moiety as Anticancer and Antimicrobial Agents, Green Biocatalyst for Ultrasound-Assisted Thiazole Derivatives: Synthesis, Antibacterial Evaluation, and Docking Analysis, Cyanauric Chloride as a Key Precursor and a Core Component for Three-Armed Triazolopyrimidines: Recent Finding About SARs and Docking Analyses, Chitosan–Sulfonic Acid-Catalyzed Green Synthesis of Naphthalene-Based Azines as Potential Anticancer Agents, Synthesis, Molecular Docking, In Silico Study, and Evaluation of Bis-Thiazole-Based Curcumin Derivatives as Potential Antimicrobial Agents, and Design and Synthesis of Novel Hybrids Incorporating Thiadiazole or Thiazole-Naphthalene: Anticancer Assessment and Molecular Docking Study.

Profile: Google Scholar

Featured Publications

Abolibda, T. Z., Fathalla, M., Farag, B., Zaki, M. E. A., & Gomha, S. M. (n.d.). Synthesis and molecular docking of some novel 3-thiazolyl-coumarins as inhibitors of VEGFR-2 kinase. Molecules.

Ibrahim, M. S., Farag, B., Al-Humaidi, J. Y., Zaki, M. E. A., Fathalla, M., & Gomha, S. M. (n.d.). Mechanochemical synthesis and molecular docking studies of new azines bearing indole as anticancer agents. Molecules.

Gomha, S. M., Riyadh, S. M., Alharbi, R. A. K., Zaki, M. E. A., Abolibda, T. Z., & Farag, B. (n.d.). Green route synthesis and molecular docking of azines using cellulose sulfuric acid under microwave irradiation. Crystals.

Al-Humaidi, J. Y., Gomha, S. M., El-Ghany, N. A. A., Farag, B., Zaki, M. E. A., et al. (n.d.). Green synthesis and molecular docking study of some new thiazoles using terephthalohydrazide chitosan hydrogel as ecofriendly biopolymeric catalyst. Catalysts.

Hussein, A. M., Gomha, S. M., El-Ghany, N. A. A., Zaki, M. E. A., Farag, B., et al. (n.d.). Green biocatalyst for ultrasound-assisted thiazole derivatives: Synthesis, antibacterial evaluation, and docking analysis. ACS Omega.

Mokbel, W. A., Hosny, M. A., Gomha, S. M., Zaki, M. E. A., Farag, B., El Farargy, A. F., et al. (n.d.). Synthesis, molecular docking study, and biological evaluation of new thiadiazole and thiazole derivatives incorporating isoindoline-1,3-dione moiety as anticancer and antimicrobial agents. Results in Chemistry.

Katiane – Medicinal Chemistry – Best Researcher Award

Katiane - Medicinal Chemistry - Best Researcher Award

UFPE - Brazil

Introduction

Katiane Cruz Magalhães Xavier is a dedicated researcher in the field of chemistry, with a particular focus on inorganic chemistry, materials science, and environmental applications. Her academic journey has led her to explore a wide range of topics, including the activation of clays for industrial applications, the use of natural materials for oil clarification, and the development of sustainable solutions for biotechnological purposes. Currently pursuing a PhD in Chemistry at the Federal University of Pernambuco (UFPE), her work continues to push the boundaries of chemical research with an emphasis on both academic and practical outcomes.

Inorganic Chemistry and Clay Activation

Katiane's research on the thermal activation of palygorskite, a natural clay mineral, has contributed significantly to the field of inorganic chemistry. Her work on using thermally activated palygorskite to clarify soybean oil, published in Applied Clay Science (2016), has garnered attention for its potential to improve industrial processes related to oil purification. This study not only highlights the utility of clay materials but also presents an environmentally friendly alternative to conventional oil clarification methods.

Materials Science and Surface Modifications

Katiane has also made substantial contributions to materials science, particularly in understanding the effects of acid treatment on clay minerals. Her collaborative research, featured in Materials Research (2014), examined how acid treatment alters the surface area, morphology, and chemical composition of palygorskite, paving the way for more efficient applications of clays in various industries. These insights are crucial for the development of enhanced materials that are both functional and sustainable.

Environmental and Biotechnological Applications

As part of her doctoral research at UFPE, Katiane is exploring the use of macroalgae from the Pernambuco coast. Her project, titled Macroalgae from the Pernambuco Coast: From the Use of Crude Extracts to Electrospun Films for Biotechnological Applications, focuses on harnessing the biotechnological potential of marine resources. By creating electrospun films from macroalgae extracts, she aims to develop innovative materials for use in various biotechnological fields, including medicine, environmental science, and materials engineering.

Oil Purification and Environmental Sustainability

Katiane's work on oil clarification extends beyond traditional chemical methods and emphasizes environmentally sustainable approaches. Her research into using thermally activated clays, particularly in the context of soybean oil purification, offers a green alternative to chemical treatments. This work aligns with global trends in minimizing the environmental impact of industrial processes and contributes to the development of cleaner technologies in the food and pharmaceutical industries.

Interdisciplinary Research in Chemistry

Katiane's research is rooted in the intersection of several disciplines, including inorganic chemistry, materials science, and environmental chemistry. Her ability to bridge these areas allows for a holistic approach to problem-solving, addressing both practical and theoretical challenges. This interdisciplinary methodology has equipped her with the skills to develop solutions that are not only scientifically sound but also applicable in real-world scenarios.

Conclusion

Katiane Cruz Magalhães Xavier’s academic and research career has been defined by her commitment to advancing the fields of inorganic chemistry, materials science, and biotechnological applications. Through her innovative work on clay activation, oil clarification, and macroalgae-based materials, she continues to contribute valuable knowledge that could have far-reaching implications in both industrial and environmental sectors. As a doctoral candidate at UFPE, her research promises to further enhance our understanding of natural materials and their potential for sustainable development.

NOTABLE PUBLICATION

Thermally activated palygorskites as agents to clarify soybean oil

Effects of acid treatment on the clay palygorskite: XRD, surface area, morphological and chemical composition

Rahul K. Reddy – Pharmacology – Excellence in Research

Rahul K. Reddy - Pharmacology - Excellence in Research

Lautoka Hospital - Fiji

Introduction

Rahul K. Reddy is an accomplished researcher and medical professional specializing in urology, surgery, and trauma care. With a focus on advancing medical understanding and clinical outcomes in challenging cases, Dr. Reddy has contributed significantly to the fields of laparoscopic surgery, burn care, and acute surgical conditions. His work is characterized by its depth of clinical insight and dedication to improving patient outcomes in diverse healthcare settings, particularly in Fiji.

Laparoscopic Surgery in Urology

Dr. Reddy's pioneering work in the laparoscopic excision of seminal vesicle cystadenoma underscores his expertise in minimally invasive surgical techniques. Published in Urology Case Reports (2019), this study has provided valuable insights into rare urological conditions, offering innovative approaches to their management.

Burn Injury Characteristics and Outcomes

In collaboration with a multidisciplinary team, Dr. Reddy conducted an in-depth analysis of burn injury patterns and treatment outcomes at Lautoka Hospital. His findings, featured in Burns Open (2024), have contributed to the optimization of burn care protocols in resource-limited settings, enhancing recovery rates and patient care quality.

Acute Appendicitis Management

Through an observational retrospective study on acute appendicitis at Lautoka Aspen Hospital, Dr. Reddy explored the clinical characteristics and outcomes over a one-year period (2022–2023). Published in World Journal of Surgical Research (2024), this research offers evidence-based recommendations for improving appendicitis management in Pacific Island healthcare systems.

Rare Tumors and Pathologies

Dr. Reddy has also delved into the study of rare pathologies, such as primary epithelioid hemangioendothelioma of the kidney pelvis. His case report, published in the American Journal of Surgery and Clinical Case Reports (2020), adds to the limited literature on this rare tumor type, emphasizing the importance of early diagnosis and tailored surgical interventions.

Trauma and Emergency Medicine

With a holistic approach to trauma care, Dr. Reddy's research addresses the critical needs of patients in emergency settings. His work highlights the significance of multidisciplinary collaboration and protocol-driven management in achieving favorable outcomes for complex trauma cases.

Conclusion

Rahul K. Reddy’s extensive research portfolio reflects his unwavering commitment to advancing medical science and improving patient care. By addressing diverse challenges in urology, surgery, and trauma care, Dr. Reddy continues to contribute to the development of innovative treatments and clinical best practices, with a lasting impact on global and regional healthcare.

NOTABLE PUBLICATION

Laparoscopic excision of seminal vesicle cystadenoma 2019 (4)

Burns injury characteristics and outcomes at lautoka hospital, fiji 2024

Characteristics and Outcomes of Acute Appendicitis in Lautoka Aspen Hospital, Fiji: An Observational Retrospective Study (09/22–09/23) 2024

Primary Epithelioid Hemangioendothelioma of the Kidney Pelvis 2020